Qinglin Song

Jiaozuo, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Prognostic significance of CD56 expression in newly diagnosed multiple myeloma and its correlation with clinicopathological features.

Prognostic significance of CD56 expression in newly diagnosed multiple myeloma and its correlation with clinicopathological features.

Journal: Frontiers in oncology

Published: April 14, 2026

All-trans retinoic acid combined with the VAH regimen for EVI1-positive acute myeloid leukemia: a case report with a brief literature review.

All-trans retinoic acid combined with the VAH regimen for EVI1-positive acute myeloid leukemia: a case report with a brief literature review.

Journal: Frontiers in oncology

Published: January 17, 2026

Identification of the Novel HLA-DQA1*03:03:11 Allele by Third-Generation Sequencing in a Chinese Individual.

Identification of the Novel HLA-DQA1*03:03:11 Allele by Third-Generation Sequencing in a Chinese Individual.

Journal: HLA

Published: November 14, 2025

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review.

Obinutuzumab combined with bendamustine for the treatment of hairy cell leukemia variant: a case report and literature review.

Journal: Frontiers in oncology

Published: May 27, 2025

Acute myeloid leukemia with plasmacytoid dendritic cell proliferation: A case report and literature review.

Acute myeloid leukemia with plasmacytoid dendritic cell proliferation: A case report and literature review.

Journal: Oncology letters

Published: February 10, 2025

Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review.

Alectinib combined with VRCD and BV monoclonal antibody for the treatment of ALK-positive large B-cell lymphoma: a case report and literature review.

Journal: Frontiers in oncology

Published: August 14, 2024

A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states.

A retrospective study on effectiveness of combined recombinant human interferon-α-1b, interleukin-2, and thalidomide for the treatment of acute myeloid leukemia in various disease states.

Journal: Annals of translational medicine

Published: October 20, 2022

Chidamide and Decitabine in Combination with a HAG Priming Regimen for Acute Myeloid Leukemia with TP53 Mutation.

Chidamide and Decitabine in Combination with a HAG Priming Regimen for Acute Myeloid Leukemia with TP53 Mutation.

Journal: Acta medica Okayama

Published: March 03, 2022

Clinical Value of Serum miRNA in Patients with Acute Promyelocytic Leukemia.

Clinical Value of Serum miRNA in Patients with Acute Promyelocytic Leukemia.

Journal: Journal of oncology

Published: January 19, 2022

Venetoclax + hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia: Two case reports.

Venetoclax + hypomethylating agents combined with dose-adjusted HAG for relapsed/refractory acute myeloid leukemia: Two case reports.

Journal: Medicine

Published: November 21, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026